295 results
8-K
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
) reserves and expenses related to finalizing an escheatment audit with the State of Delaware in a total amount equal to or around $600,000 expected
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
audit with the State of Delaware in a total amount equal to or around $600,000 expected to be paid during the second quarter of 2024; plus
(vii
8-K
EX-99.1
abm2m7 if4g
5 Jan 24
Results of Operations and Financial Condition
5:01pm
8-K
ywuo6x6c2n0a
5 Jan 24
Results of Operations and Financial Condition
5:01pm
8-K
9smaw7hu k8
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-99.1
uwij5m1bl m0eq
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
SD
EX-1.01
n72m1v4
30 May 23
Conflict minerals disclosure
4:17pm
8-K
lz0227y lmsx
12 Dec 22
Harvard Bioscience Announces CFO Transition
8:31am